GEST 2013 Europe

Welcome Address

Dear Colleagues,

Embolotherapy, performed by Interventional Radiologists, occupies a central and unique role in patient care. Among the many conditions treated with embolization are uterine fibroids, vascular malformations, blunt and penetrating trauma, and gastrointestinal haemorrhage. The indications for embolic therapies have expanded over the last decade and this trend will continue into the future. Interventional Oncology, an area where embolization of hepatic tumours has been paramount for two decades, has witnessed dramatic advances with the introduction of drug-eluting embolics and radioembolization.

The GEST 2013 Europe conference will be devoted entirely to embolization and will build on the success of the six successful prior years of GEST. In 2011 GEST Europe, held in Paris, France, attracted over 1,000 attendees. For GEST 2013 Europe, the CIRSE Foundation has again joined forces with all the 2011 organisers to create a cutting-edge meeting dedicated exclusively to Embolotherapy.

GEST 2013 Europe will take place from May 1-4, 2013 in Prague, Czech Republic.

We are very much looking forward to meeting you in Prague in 2013.

The GEST Advisory Board

Jafar Golzarian (US)
Ziv Haskal (US)
Michael J. Lee (IE)
Jan H. Peregrin (CZ)
Marc R. Sapoval (FR)

Further information on GEST Europe 2013 can be found at www.gest2013.eu.